These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16955232)

  • 1. Expert stakeholders' views on the management of human pharmaceuticals in the environment.
    Doerr-MacEwen NA; Haight ME
    Environ Manage; 2006 Nov; 38(5):853-66. PubMed ID: 16955232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Household Disposal of Pharmaceuticals in Lebanon: Management Options to Protect Water Quality and Public Health.
    Massoud MA; Chami G; Al-Hindi M; Alameddine I
    Environ Manage; 2016 May; 57(5):1125-37. PubMed ID: 26847599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U.S. News Media Coverage of Pharmaceutical Pollution in the Aquatic Environment: A Content Analysis of the Problems and Solutions Presented by Actors.
    Blair B; Zimny-Schmitt D; Rudd MA
    Environ Manage; 2017 Aug; 60(2):314-322. PubMed ID: 28493015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Upstream Strategies for the Mitigation of Pharmaceuticals in the Aquatic Environment: a Brief Review.
    Blair BD
    Curr Environ Health Rep; 2016 Jun; 3(2):153-60. PubMed ID: 27068434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence patterns of pharmaceuticals in water and wastewater environments.
    Nikolaou A; Meric S; Fatta D
    Anal Bioanal Chem; 2007 Feb; 387(4):1225-34. PubMed ID: 17205270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic screening of common wastewater-marking pharmaceuticals in urban aquatic environments: implications for environmental risk control.
    Zhou H; Zhang Q; Wang X; Zhang Q; Ma L; Zhan Y
    Environ Sci Pollut Res Int; 2014; 21(11):7113-29. PubMed ID: 24557805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds.
    Camacho-Muñoz MD; Santos JL; Aparicio I; Alonso E
    J Hazard Mater; 2010 May; 177(1-3):1159-62. PubMed ID: 20122798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
    Zenker A; Cicero MR; Prestinaci F; Bottoni P; Carere M
    J Environ Manage; 2014 Jan; 133():378-87. PubMed ID: 24419205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control.
    Zuccato E; Castiglioni S; Fanelli R; Reitano G; Bagnati R; Chiabrando C; Pomati F; Rossetti C; Calamari D
    Environ Sci Pollut Res Int; 2006 Jan; 13(1):15-21. PubMed ID: 16417127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why regulatory indifference towards pharmaceutical pollution of the environment could be a missed opportunity in public health protection. a holistic view.
    Kamba PF; Kaggwa B; Munanura EI; Okurut T; Kitutu FE
    Pan Afr Med J; 2017; 27():77. PubMed ID: 28819498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.
    Huerta B; Rodríguez-Mozaz S; Barceló D
    Anal Bioanal Chem; 2012 Nov; 404(9):2611-24. PubMed ID: 22678760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pharmaceuticals in the arctic - A review.
    Dube N; Smolarz K; Sokołowski A; Świeżak J; Øverjordet IB; Ellingsen I; Wielogórska E; Sørensen L; Walecka D; Kwaśniewski S
    Chemosphere; 2024 Sep; 364():143172. PubMed ID: 39182731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JEM spotlight: recent advances in analysis of pharmaceuticals in the aquatic environment.
    Wong CS; MacLeod SL
    J Environ Monit; 2009 May; 11(5):923-36. PubMed ID: 19436850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: review of evidence and need for knowledge.
    Cardoso O; Porcher JM; Sanchez W
    Chemosphere; 2014 Nov; 115():20-30. PubMed ID: 24602347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms.
    Mezzelani M; Gorbi S; Regoli F
    Mar Environ Res; 2018 Sep; 140():41-60. PubMed ID: 29859717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Prioritisation Schemes for Human Pharmaceuticals in the Aquatic Environment.
    Letsinger S; Kay P
    Environ Sci Pollut Res Int; 2019 Feb; 26(4):3479-3491. PubMed ID: 30515684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecotoxicology of human pharmaceuticals.
    Fent K; Weston AA; Caminada D
    Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pollution pathways of pharmaceutical residues in the aquatic environment on the island of Mallorca, Spain.
    Rodríguez-Navas C; Björklund E; Bak SA; Hansen M; Krogh KA; Maya F; Forteza R; Cerdà V
    Arch Environ Contam Toxicol; 2013 Jul; 65(1):56-66. PubMed ID: 23440447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration and risk of pharmaceuticals in freshwater systems are related to the population density and the livestock units in Iberian Rivers.
    Osorio V; Larrañaga A; Aceña J; Pérez S; Barceló D
    Sci Total Environ; 2016 Jan; 540():267-77. PubMed ID: 26170112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.